Filter
4443
Filtered Results: 4443
Text search:
efficacy
Featured
Recommendations
448
New Publications
989
Language
Document type
No document type
2278
Guidelines
826
Studies & Reports
683
Manuals
207
Strategic & Response Plan
159
Fact sheets
125
Training Material
85
Situation Updates
25
Resource Platforms
16
Infographics
16
Brochures
13
Online Courses
6
Videos
4
Countries / Regions
Global
168
India
147
Congo, Democratic Republic of
130
Senegal
116
South Africa
87
Kenya
83
Burkina Faso
77
Africa
66
Ethiopia
64
Uganda
63
Western and Central Europe
57
Benin
54
Nigeria
54
Haiti
50
Latin America and the Carribbean
50
Tanzania
50
Sierra Leone
49
Rwanda
46
West and Central Africa
44
Liberia
44
Zambia
43
Nepal
42
Malawi
40
Guinea
40
Cameroon
39
Ghana
35
Russia
33
Bangladesh
31
East and Southern Africa
30
Mali
29
Eastern Europe
27
Zimbabwe
25
Philippines
25
Brazil
25
South–East Asia Region
24
Indonesia
24
Ukraine
22
Côte d’Ivoire / Ivory Coast
22
Myanmar / Burma
22
Madagascar
22
Mozambique
21
Central African Republic
21
Middle East and North Africa
20
Namibia
19
Germany
18
Syria
17
Cambodia
17
Niger
16
Lesotho
15
Botswana
14
Chad
13
Pakistan
13
South Sudan
11
Eswatini/ Swaziland
11
Asia
10
Argentina
10
Eastern Europe and Central Asia
9
Togo
8
Chile
8
Sri Lanka
8
Sudan
8
Angola
8
Laos
7
Peru
7
USA
7
Somalia
7
Thailand
6
Afghanistan
6
Jordan
6
Western Pacific Region
6
Paraguay
6
Vietnam
6
Yemen
6
Tajikistan
5
Colombia
5
China
5
Italy
5
Guinea-Bissau
5
North America
5
United Kingdom
5
Georgia
5
Iraq
5
Iran
4
Burundi
4
Venezuela
4
France
4
Lebanon
4
Ecuador
4
North Macedonia
3
Morocco
3
Armenia
3
Tunisia
3
Bhutan
3
Switzerland
2
Mexico
2
Turkey
2
Albania
2
Canada
2
Congo-Brazzaville
2
Mauritania
2
Gabon
2
Portugal
2
Spain
2
Papua New Guinea
2
Libya
2
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Gambia
1
Kazakhstan
1
Fiji
1
Singapore
1
Kyrgyzstan
1
Uzbekistan
1
Qatar
1
Ireland
1
Saudi Arabia
1
Denmark
1
Belgium
1
Mauritius
1
Algeria
1
Belarus
1
Bolivia
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
1509
Clinical Guidelines
468
Public Health
263
Women & Child Health
233
Key Resources
186
Capacity Building
70
Pharmacy & Technologies
54
Toolboxes
COVID-19
514
Mental Health
405
HIV
307
TB
243
NTDs
197
AMR
184
Ebola & Marburg
159
Rapid Response
147
Pharmacy
139
Caregiver
121
Disability
103
Planetary Health
88
NCDs
83
Refugee
53
Cholera
35
Conflict
31
Global Health Education
30
Polio
24
Natural Hazards
20
Zika
19
Health Financing Toolbox
17
Social Ethics
15
Specific Hazards
12
Malaria
8
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifa...
West Africa is experiencing the largest, most severe, most complex outbreak of Ebola virus disease in history. On 11 August 2014, WHO convened a consultation where the participants concluded that in the particular context of the current Ebola outbreak in West Africa, it is ethically acceptable to of...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
BMJ Global Health, Vol. 4 (2019) no.2
Antibiotic resistance is threatening global health, development and food security; however, measures for assessing and communicating the threat of resistance are lacking. The Drug Resistance Index (DRI) allows for global assessment of the relative efficacy of ...
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-...
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
Similar to other parts of the world, the prevalence of type 2 diabetes mellitus (T2DM) in the Asia-Pacific Region has rapidly increased during the last few decades. The purposes of this pilot study were to determine the feasibility and the effects of a capacity building program for Village Health Vo...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
Acupuncture has been practised for more than 2500 years in the Western Pacific Region and has become a global therapeutic method in recent decades. However, it was reportedthat acupuncturists differed by up to 25% in the acupuncture points they used, raising doubts and uncertainty regarding the effi...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
The evolving epidemic of type 2 diabetes mellitus has challenged health-care professionals. It stands among the leading causes of mortality in the present world. It warrants new and versatile approaches to improve mortality and the associated huge quality-adjusted life years lost to it once diagnose...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Cognitive deficits in schizophrenia can massively impact functionality and quality of life, furthering the importance of cognitive training. Despite the development of the field in Europe and in the United States, no programmes have been developed and tested in developing countries. Different cultur...
